scholarly journals Long-term survivor of metastatic squamous-cell head and neck carcinoma with occult primary after cetuximab-based chemotherapy: A case report

2021 ◽  
Vol 9 (24) ◽  
pp. 7092-7098
Author(s):  
Christina Große-Thie ◽  
Claudia Maletzki ◽  
Christian Junghanss ◽  
Kathie Schmidt
JAMA Oncology ◽  
2017 ◽  
Vol 3 (2) ◽  
pp. 220 ◽  
Author(s):  
Lillian L. Siu ◽  
John N. Waldron ◽  
Bingshu E. Chen ◽  
Eric Winquist ◽  
Jim R. Wright ◽  
...  

Cancer ◽  
2005 ◽  
Vol 104 (7) ◽  
pp. 1408-1417 ◽  
Author(s):  
Johannes A. Langendijk ◽  
Ben J. Slotman ◽  
Isaac van der Waal ◽  
P. Doornaert ◽  
Johannes Berkof ◽  
...  

Head & Neck ◽  
2001 ◽  
Vol 23 (4) ◽  
pp. 298-304 ◽  
Author(s):  
Mario Airoldi ◽  
Antonella De Stefani ◽  
Sara Marchionatti ◽  
Fulvia Pedani ◽  
Pietro Gabriele ◽  
...  

1997 ◽  
Vol 36 (3) ◽  
pp. 267-271 ◽  
Author(s):  
Abdelkarim S. Allal ◽  
Raymond Miralbell ◽  
Gudrun Pipard ◽  
Claire Guillemin ◽  
Willy Lehmann ◽  
...  

2011 ◽  
Vol 10 (1) ◽  
pp. 55-58
Author(s):  
Ye. V. Klisho ◽  
I. V. Kondakova ◽  
Ye. L. Choynzonov ◽  
O. V. Cheremisina ◽  
D. A. Shishkin

The concentrations of matrix metalloproteinases (MMP-2, -3, -9) and their tissue inhibitors (TIMP-1, -2) were studied in blood serum of 193 patients with squamous cell head and neck carcinoma (SCHNC) and in 38 healthy donors using immunoenzymatic assay. The decreased MMP-3 and TIMP-1, -2 levels were found in patients with oral cavity tumors as compared to patients with laryngeal cancer. The serum MMP-9 and TIMP-1 levels were significantly higher in head and neck cancer patients than in healthy subjects. High TIMP-1 and MMP-9 levels in blood serum of patients with SCHNC should be greatly attended for detection of their predictive and prognostic significances.


Sign in / Sign up

Export Citation Format

Share Document